ETANERCEPT Side Effects

6999816-7 | Breast Cancer Female
on Sep 09, 2010 Female patient from JAPAN , 51 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female. Etanercept dosage: . During the same period patient was treated with ACTEMRA (View Actemra Review and Actemra Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6963711-X | Dermatomyositis
Patient was taking Etanercept (View Usage). Patient had the following side effects: dermatomyositis on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with ADALIMUMAB (View Adalimumab Review and Adalimumab Label ).

6915490-X | Cough, Laryngospasm, Wheezing
Adverse event was reported on Aug 06, 2010 by a Male patient taking Etanercept (View Usage) (Dosage: 50 Mg Qweek Sq) was diagnosed with pain (What is pain?), rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 82 years of age, weighting 142.9 lb, After Etanercept was administered, patient had the following side effects: cough, laryngospasm, wheezing.

6851202-6 | Asthma
on Jul 08, 2010 Female patient from UNITED STATES , weighting 257.5 lb, was diagnosed with psoriasis and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?). Etanercept dosage: . During the same period patient was treated with ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZANAFLEX (View Zanaflex Review and Zanaflex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SINGULAIR (View Singulair Review and Singulair Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.


6844957-8 | Myocardial Infarction
on Jul 07, 2010 Female patient from UNITED STATES , weighting 235.2 lb, was diagnosed with psoriasis and was treated with Etanercept (View Usage). Patient had the following side effects: myocardial infarction. Etanercept dosage: . During the same period patient was treated with HUMULIN R (View Humulin R Review and Humulin R Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ). Patient was hospitalized.

6832089-4 | Pericardial Effusion, Pyrexia
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: pericardial effusion, pyrexia on Jun 28, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ). Patient was hospitalized.

6831179-X | Abdominal Pain, Colon Cancer, Diarrhoea Haemorrhagic, Infusion Related Reaction, Intestinal Polyp
Adverse event was reported on Jul 09, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: 25 Mg Twice Weekly Sq) was diagnosed with infusion, intestinal polyp and. Location: UNITED STATES , 18 years of age, weighting 88.18 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), colon cancer, diarrhoea haemorrhagic, infusion related reaction, intestinal polyp. During the same period patient was treated with INFLIXIMAB (Monthly Iv) (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6831141-7 | Condition Aggravated, Juvenile Arthritis
on Jun 28, 2010 Female patient from UNITED KINGDOM , weighting 185.4 lb, was diagnosed with juvenile arthritis and was treated with Etanercept (View Usage). Patient had the following side effects: condition aggravated, juvenile arthritis. Etanercept dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6820367-4 | Extranodal Marginal Zone B-cell Lymphoma (malt Type)
on Jun 23, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: extranodal marginal zone b-cell lymphoma (malt type). Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6820360-1 | Extranodal Marginal Zone B-cell Lymphoma (malt Type)
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: extranodal marginal zone b-cell lymphoma (malt type) on Jun 23, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: .

6818685-9 | Bursitis
Adverse event was reported on Jun 23, 2010 by a Male patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: GERMANY , 45 years of age, Patient had the following side effects: bursitis (What is bursitis?). Patient was hospitalized.

6815708-8 | Asthma
on Jun 24, 2010 Female patient from UNITED STATES , weighting 257.5 lb, was diagnosed with psoriasis and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: asthma (What is asthma?). Etanercept dosage: . During the same period patient was treated with ALBUTEROL SULATE (View Albuterol Sulate Review and Albuterol Sulate Label ). Patient was hospitalized.

6806570-8 | Lymphohistiocytosis
on Jun 14, 2010 Female patient from , 65 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: lymphohistiocytosis. Etanercept dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6806569-1 | Lymphohistiocytosis
Patient was taking Etanercept (View Usage). Patient had the following side effects: lymphohistiocytosis on Jun 14, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6806476-4 | Lymphohistiocytosis
Adverse event was reported on Jun 14, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 40 years of age, After Etanercept was administered, patient had the following side effects: lymphohistiocytosis. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6806191-7 | Arrhythmia, Condition Aggravated, Metabolic Acidosis, Renal Failure, Rheumatoid Lung
on Jun 14, 2010 Female patient from UNITED KINGDOM , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), condition aggravated, metabolic acidosis, renal failure, rheumatoid lung. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6806088-2 | Concomitant Disease Progression, Condition Aggravated, Interstitial Lung Disease, Seronegative Arthritis
on Jun 14, 2010 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: concomitant disease progression, condition aggravated, interstitial lung disease, seronegative arthritis. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6802982-7 | Condition Aggravated, Interstitial Lung Disease
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: condition aggravated, interstitial lung disease on Jun 14, 2010 from FRANCE Additional patient health information: Male patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6801201-5 | Inflammatory Bowel Disease
Adverse event was reported on Jun 16, 2010 by a Male patient taking Etanercept (View Usage) (Dosage: Not Specified) was diagnosed with juvenile arthritis and. Location: FRANCE , 14 years of age, Patient experienced the following unwanted or unexpected effects: inflammatory bowel disease. During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ).

6792581-8 | Lip And/or Oral Cavity Cancer
on Jun 16, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with polyarthritis, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: lip and/or oral cavity cancer. Etanercept dosage: . During the same period patient was treated with KINERET (View Kineret Review and Kineret Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), PRETERAX (View Preterax Review and Preterax Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CORTISONE (View Cortisone Review and Cortisone Label ), ARTOTEC (View Artotec Review and Artotec Label ). Patient was hospitalized.

6792580-6 | Abortion Complete
on Jun 16, 2010 Female patient from JAPAN , weighting 106.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis (What is osteoporosis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: abortion complete. Etanercept dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6771451-5 | Myasthenia Gravis
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: myasthenia gravis on Jun 07, 2010 from ITALY Additional patient health information: Female patient , 68 years of age, was diagnosed with psoriatic arthropathy and. Etanercept dosage: . Patient was hospitalized.

6770664-6 | Erythema Multiforme
Adverse event was reported on Jun 04, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 32 years of age, Patient had the following side effects: erythema multiforme.

6762811-7 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy
on May 25, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: chronic inflammatory demyelinating polyradiculoneuropathy. Etanercept dosage: .

6762518-6 | Demyelinating Polyneuropathy
on May 25, 2010 Female patient from FRANCE , weighting 196.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: demyelinating polyneuropathy. Etanercept dosage: . During the same period patient was treated with SULPHASALAZINE (2-3 Grams As Per Protocol Administered Twice Daily) (View Sulphasalazine Review and Sulphasalazine Label ), NISISCO (View Nisisco Review and Nisisco Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6759495-0 | Bile Duct Stone, Cholecystitis, Cholelithiasis, Hepatic Steatosis, Hyperplastic Cholecystopathy
Patient was taking Etanercept (View Usage). Patient had the following side effects: bile duct stone, cholecystitis, cholelithiasis, hepatic steatosis, hyperplastic cholecystopathy on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 214.3 lb, was diagnosed with psoriasis and. Etanercept dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6752575-5 | Cholecystitis, Cholelithiasis
Adverse event was reported on May 25, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 214.3 lb, After Etanercept was administered, patient had the following side effects: cholecystitis, cholelithiasis. During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6713738-8 | Dehydration, Pharyngitis
on Apr 26, 2010 Female patient from UNITED STATES , 14 years of age, weighting 114.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pharyngitis. Etanercept dosage: . Patient was hospitalized.

6712904-5 | Acid Fast Bacilli Infection, Atypical Mycobacterium Test Positive, Pain Of Skin, Skin Lesion
on May 04, 2010 Male patient from UNITED STATES , weighting 178.4 lb, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Etanercept (View Usage). Patient had the following side effects: acid fast bacilli infection, atypical mycobacterium test positive, pain of skin, skin lesion. Etanercept dosage: 50mg Qweek Im.

6702861-X | Atrial Fibrillation, Escherichia Infection, Palpitations, Sepsis, Urinary Tract Infection
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), escherichia infection, palpitations, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?) on Apr 29, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: 50 Mg Qweek Sq. Patient was hospitalized.

6688463-2 | Diffuse Large B-cell Lymphoma, Uterine Leiomyoma
Adverse event was reported on Apr 07, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 52 years of age, Patient experienced the following unwanted or unexpected effects: diffuse large b-cell lymphoma, uterine leiomyoma. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6684257-2 | Demyelination, Neuropathy Peripheral
on Apr 06, 2010 Female patient from UNITED STATES , 47 years of age, weighting 146.2 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: demyelination, neuropathy peripheral. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), VALIUM (View Valium Review and Valium Label ), XANAX (View Xanax Review and Xanax Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6684244-4 | Psychotic Disorder
on Apr 06, 2010 Female patient from UNITED STATES , 39 years of age, weighting 141.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized.

6684240-7 | Ovarian Cyst, Vaginal Haemorrhage
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cyst (What is ovarian cyst?), vaginal haemorrhage on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , 36 years of age, weighting 176.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), SALSALATE (View Salsalate Review and Salsalate Label ).

6640819-X | Cerebrovascular Accident, Meningitis Tuberculous, Normal Pressure Hydrocephalus
Adverse event was reported on Mar 05, 2010 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , 74 years of age, Patient had the following side effects: cerebrovascular accident, meningitis tuberculous, normal pressure hydrocephalus. During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), LEFLUNOMIDE (10 Mg Every 1 Cyc) (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized.

6630931-3 | Sarcoidosis
on Mar 02, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with psoriasis, psoriatic arthropathy and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: sarcoidosis. Etanercept dosage: .

6619134-6 | Cellulitis Streptococcal, Streptococcal Abscess
on Mar 05, 2010 Male patient from UNITED STATES , 59 years of age, was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis streptococcal, streptococcal abscess. Etanercept dosage: . Patient was hospitalized.

6602627-5 | Mycosis Fungoides
Patient was taking Etanercept (View Usage). Patient had the following side effects: mycosis fungoides on Feb 16, 2010 from NETHERLANDS Additional patient health information: Male patient , 67 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6545812-3 | Malignant Urinary Tract Neoplasm
Adverse event was reported on Jan 11, 2010 by a Male patient taking Etanercept (View Usage) (Dosage: Treatment ^ab^ - Etan 50+mtx/etan25+mtx) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: RUSSIAN FEDERATION , weighting 181.9 lb, After Etanercept was administered, patient had the following side effects: malignant urinary tract neoplasm. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6522850-8 | Lip And/or Oral Cavity Cancer
on Dec 22, 2009 Female patient from FRANCE , 82 years of age, was diagnosed with polyarthritis and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: lip and/or oral cavity cancer. Etanercept dosage: . During the same period patient was treated with CORTISONE (View Cortisone Review and Cortisone Label ). Patient was hospitalized.

6520925-0 | Bronchopulmonary Aspergillosis
on Dec 16, 2009 Male patient from JAPAN , 82 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: bronchopulmonary aspergillosis. Etanercept dosage: 25 Mg/a Week Or Two Weeks. During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

6517269-X | Cellulitis, Renal Failure
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: cellulitis (What is cellulitis?), renal failure on Dec 14, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), amyloidosis and. Etanercept dosage: . During the same period patient was treated with CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ).

6515870-0 | Arthritis Infective, Decreased Appetite, Extrapulmonary Tuberculosis
Adverse event was reported on Dec 10, 2009 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: KOREA, REPUBLIC OF , 57 years of age, Patient experienced the following unwanted or unexpected effects: arthritis infective, decreased appetite, extrapulmonary tuberculosis. During the same period patient was treated with ACECLOFENAC (View Aceclofenac Review and Aceclofenac Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6488690-3 | Haematuria, Neoplasm, Polyp
on Dec 01, 2009 Male patient from RUSSIAN FEDERATION , weighting 181.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: haematuria, neoplasm, polyp. Etanercept dosage: Treatment ^ab^ - Etan 50+mtx/etan25+mtx. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6458272-8 | Haematuria, Neoplasm, Polyp
on Nov 16, 2009 Male patient from RUSSIAN FEDERATION , weighting 181.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: haematuria, neoplasm, polyp. Etanercept dosage: Treatment ^ab^ - Etan 50+mtx/etan25+mtx. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6458258-3 | Demyelination, Neuropathy Peripheral
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: demyelination, neuropathy peripheral on Nov 18, 2009 from MEXICO Additional patient health information: Male patient , weighting 257.9 lb, was diagnosed with psoriasis, prophylaxis, hypertension and. Etanercept dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ).

6453263-5 | Demyelinating Polyneuropathy, Demyelination, Neuropathy Peripheral
Adverse event was reported on Nov 12, 2009 by a Male patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with psoriasis, prophylaxis, hypertension and. Location: MEXICO , weighting 257.9 lb, Patient had the following side effects: demyelinating polyneuropathy, demyelination, neuropathy peripheral. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ).

6433877-9 | Sudden Hearing Loss
on Oct 26, 2009 Male patient from JAPAN , weighting 205.3 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), antibiotic prophylaxis, hypertension, hypercholesterolaemia, reflux oesophagitis and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: sudden hearing loss. Etanercept dosage: Twice Weekly Sq Injections/ Weekly Po Capsules In 2 Or 3 Divided Doses Separated By 12 Hours. During the same period patient was treated with FELBINAC (View Felbinac Review and Felbinac Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6433492-7 | Arthritis Salmonella
on Nov 06, 2009 Female patient from UNITED STATES , 69 years of age, weighting 200.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis salmonella. Etanercept dosage: 50mg, Once Weekly, Sq. Patient was hospitalized.

6430757-X | Abscess Neck, Angiopathy, Fusobacterium Infection, Neck Injury
Patient was taking Etanercept (View Usage). Patient had the following side effects: abscess neck, angiopathy, fusobacterium infection, neck injury on Nov 05, 2009 from UNITED STATES Additional patient health information: Female patient , 18 years of age, weighting 130.1 lb, was diagnosed with juvenile arthritis and. Etanercept dosage: 25 Mg Twice A Week Sq. Patient was hospitalized.